Wankyu Lee

Wankyu Lee is a Senior Research Scientist at AstraZeneca, responsible for designing and delivering mass spectrometry-based assays to support drug development and providing mechanistic insights in epigenetics and hematology. Previous experience includes serving as a Senior Scientist at Dewpoint Therapeutics, where work focused on neurodegenerative diseases and oncology, and as a Postdoctoral Researcher at Pfizer, investigating proteomic targets with bifunctional degrader molecules. Academic background includes a PhD in Biochemistry from the Massachusetts Institute of Technology, where research centered on ribonucleotide reductase mechanisms, and a BA in Chemistry from Cornell University, exploring yeast diphthamide biosynthesis.